M28 Capital Management LP Makes New $1.44 Million Investment in Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

M28 Capital Management LP purchased a new position in shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 439,300 shares of the biotechnology company’s stock, valued at approximately $1,441,000. Atara Biotherapeutics makes […]

Related Keywords

Pascal Touchon ,Wasatch Advisors Inc ,Ef Hutton Acquisition Co ,Exchange Commission ,Renaissance Technologies ,Jacobs Levy Equity Management Inc ,Nasdaq ,Goldman Sachs Group Inc ,Atara Biotherapeutics Inc ,Get Rating ,Street Corp ,Sachs Group ,Jacobs Levy Equity Management ,Visit Holdingschannel ,Atara Biotherapeutics ,Nasdaq Atra ,Tatra ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,